CONNECTS

The COVID-19 Treatment Guidelines Panel's Statement on Anticoagulation in Hospitalized Patients With COVID-19

COVID-19 has been associated with inflammation and a prothrombotic state accompanied by increases in fibrinogen and D-dimer...

Read More

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

We aimed to assess the efficacy and safety of two neutralising monoclonal antibody therapies (sotrovimab [Vir Biotechnology and GlaxoSmithKline] and BRII-196 plus BRII-198 [Brii Biosciences]) for adults admitted to hospital for COVID-19 (hereafter referred to as hospitalised) with COVID-19.

Read More

ASH Guidelines on Use of Anticoagulation in Patients with COVID-19

ASH has issued recommendations for the use of anticoagulation in critically and acutely ill patients for which the evidence will be re-evaluated in a continual fashion. This webpage will be updated as the evidence for recommendations are evaluated.

Read More